Ublituximab for treating relapsing multiple sclerosis

Evaluation committee members

The highly specialised technologies evaluation committee is a standing advisory committee of NICE. This topic was considered by the lead team of the committee, which includes the chair and vice chair.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair and vice chair

Paul Arundel and Iolo Doull
Chair and vice chair, highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Sally Lewis
Technical lead

Adam Brooke
Technical adviser

Jeremy Powell
Project manager

Emily Crowe
Associate director

ISBN: 978-1-4731-6695-0